Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Infectious diseases · J Infect Dis · 2026-10-15
Secondary analysisn = 1,502
Saavedra-Cervera et al. Dynamics of QuantiFERON-TB Gold Plus Results in a Large TB Preventive Treatment Trial Across 3 High-Burden HIV/TB CountriesInfectious diseases · Clin Infect Dis · 2026-10-07
Secondary analysisn = 3,392 households
Mohan et al. Multidimensional Poverty and Implementation Reach of Household Contact Tracing for Tuberculosis in South Africa: Analysis of a Randomized TrialInfectious diseases · Clin Infect Dis · 2026-10-07
RCTn = 210
Chang et al. Three Months of Weekly Rifapentine and Isoniazid Versus Four Months of Daily Rifampicin for Tuberculosis Infection: A Randomized Controlled TrialInfectious diseases · Int J Infect Dis · 2026-09-24
Meta-analysisn = 46,480
Alemu et al. Asymptomatic tuberculosis among household contacts of active pulmonary tuberculosis cases: a systematic review and meta-analysisInfectious diseases · J Infect Dis · 2026-09-23
Meta-analysisn = 1,044
Zhang et al. In Host Mutational Adaptation of Mycobacterium Tuberculosis Complex Strains During Tuberculosis InfectionInfectious diseases · J Infect Dis · 2026-09-23
Meta-analysisn = 220
Chung et al. Pharmacokinetics and Dose Optimization of Ethambutol in Children on First-Line Antituberculosis Therapy: An Individual Patient Data Meta-AnalysisInfectious diseases · Lancet HIV · 2026-08-17
Meta-analysisn = 235,424
Shah et al. Programmatic effectiveness of tuberculosis preventive treatment for people with HIV in six high-tuberculosis-burden countries (PROTECT): a prospective cohort study and meta-analysisInfectious diseases · BMJ · 2026-08-06
RCTn = 555
Rubinstein et al. Evaluation of patient centred digital adherence technology for tuberculosis treatment outcomes: pragmatic randomised controlled trialInfectious diseases · Clin Infect Dis · 2026-07-23
Meta-analysisn = 12 studies
Kosenko et al. Shorter Antitubercular Regimens Versus 9 Months of Isoniazid for Latent Tuberculosis in Children: A Systematic Review and Meta-AnalysisInfectious diseases · Int J Infect Dis · 2026-07-10
Meta-analysisn = 63,988
Alahmari et al. Interferon-gamma release assays versus tuberculin skin test for latent tuberculosis infection positivity among healthcare workers and first responders: a systematic review and meta-analysisInfectious diseases · Int J Infect Dis · 2026-07-08
Meta-analysisn = 59 studies
Shamebo et al. Molecular epidemiology of Mycobacterium tuberculosis in the Middle East and North Africa: A systematic review and meta-analysisInfectious diseases · Clin Infect Dis · 2026-07-08
Meta-analysisn = 39 reports
Apriani et al. Diagnostic Performance of New Commercial Interferon-Gamma Release Assays for Mycobacterium tuberculosis Infection: An Updated Systematic Review and Meta-analysisInfectious diseases · N Engl J Med · 2026-06-25
RCTn = 403
Conradie et al. A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant TuberculosisInfectious diseases · J Infect · 2026-06-17
RCTn = 67
Donovan et al. A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatmentInfectious diseases · Int J Infect Dis · 2026-06-12
Meta-analysisn = 2,851
Eshetu et al. Time to sputum culture conversion and its predictors among drug-resistant tuberculosis patients in Ethiopia: a systematic review and meta-analysisInfectious diseases · Lancet Infect Dis · 2026-05-29
RCTn = 122
Dawson et al. Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trialInfectious diseases · Clin Infect Dis · 2026-05-20
RCTn = 43
Calderin et al. Pharmacokinetics of Dexamethasone in Tuberculous MeningitisInfectious diseases · Lancet Infect Dis · 2026-05-06
RCTn = 1,172
Cossa et al. Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialInfectious diseases · J Infect Dis · 2026-04-29
RCTn = 440
Gafar et al. Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled TrialInfectious diseases · Clin Microbiol Infect · 2026-04-12
RCTn = 400
Li et al. Rifapentine dosing for drug-susceptible tuberculosis: stage 1 of a seamless phase 2/3 randomized clinical trial